(WIAT) – Torrent Pharmaceuticals Limited expands its recall for Losartan Potassium Tablet USP and Losartan Potassium / hydrochlorothiazide tablets, USP. The level of consumer due to the detection of trace amounts of an unexpected dung found in an active pharmaceutical drug (API) produced by Hetero Labs Limited.
The Recall was expanded to include additional 36 Losartan Potassium Tablet USP and 68 lots of Losartan Potassium / Hydrochlorothiazide Tablet, USP.
The infection found in the API is N-Methylnitrosobutyric acid (NMBA). The torrent only indicates many losartan-containing products containing N-Methylnitrosobutyric acid (NMBA) above the applicable daily levels of use released by the FDA.
Torrent Pharmaceuticals Limited has not received any reports of adverse events associated with it
Losartan is used to treat hypertension, hypertensive patients with Left Ventricular Hypertrophy and for the treatment of Nephropathy in Diabetic Type 2. Patients who take Losartan Potassium Tablets, USP and Losartan Potassium / Hydrochlorothiazide Tablets, the USP should continue to take their medicines, as the risk of Patient's health damage may be higher if treatment ceases immediately without any alternative treatment. Patients should contact their pharmacist or physician who can advise them of an alternative treatment before their medication is restored.
The product / many included in the extended recycling is listed below in red. The product can be identified by checking the product name, manufacturer details, and batch or many bottle numbers containing these products.
To see the complete report from the FDA: https: / /www.fda.gov/Safety/Recalls/ucm636296.htm
Search 22News on Twitter Facebook  at Instagram ; send your news tips to firstname.lastname@example.org .